Titre : HCV Guidance Update Coming Soon: Mavyret and Vosevi
link : HCV Guidance Update Coming Soon: Mavyret and Vosevi
HCV Guidance Update Coming Soon: Mavyret and Vosevi
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) with the International Antiviral Society developed a living document with ever evolving guidelines to treat HCV.
The guidelines have a complex algorithm for practitioners around the country to follow and see what's the right treatment, for the right patients, for the right about of time. The document is beneficial for patients as well living with or treating HCV. When new HCV drugs are approved, and new real world data is established, the guidelines are updated.
Glecaprevir/pibrentasvir and sofosbuvir/ velpatasvir/voxilaprevir have been approved by the FDA- update coming soon.
In addition to updates for all relevant sections in response to the new approvals, the following new sections will be released soon:
In addition to updates for all relevant sections in response to the new approvals, the following new sections will be released soon:
- HCV in Children
- HCV in Pregnancy
- HCV Resistance Primer
Stay current with all guideline updates, "click here."
On This Blog
Mavyret (AbbVie) and Vosevi (Gilead Sciences)Thus articles HCV Guidance Update Coming Soon: Mavyret and Vosevi
that is all articles HCV Guidance Update Coming Soon: Mavyret and Vosevi This time, hopefully can provide benefits to you all. Okay, see you in another article post.
You are now reading the article HCV Guidance Update Coming Soon: Mavyret and Vosevi the link address https://newsaninpiration.blogspot.com/2017/09/hcv-guidance-update-coming-soon-mavyret.html
0 Response to "HCV Guidance Update Coming Soon: Mavyret and Vosevi"
Post a Comment